Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rey

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 14, 2026
Systematic Three-Site vs. Classical Single-Site Screening for C. trachomatis and N. gonorrhoeae Infections in Non-Sex Worker Women: The Multicentric SIST'RS StudyThierry Prazuck, Gwenael L E Moal, Axel Ursenbach, et al.
Medicine|October 15, 2016
First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral loadIsabelle Poizot-Martin, Clotilde Allavena, Cyrille Delpierre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2019
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY TrialLaurent Hocqueloux, François Raffi, Thierry Prazuck, et al.
International Journal of Pharmaceutics|October 8, 2022
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat modelXurxo García-Otero, Cristina Mondelo-García, Enrique Bandín-Vilar, et al.
Plos One|March 4, 2015
Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in FranceLaure-Amélie de Monteynard, Rosemary Dray-Spira, Pierre de Truchis, et al.
Plos One|November 1, 2018
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in FranceLaure-Amélie de Monteynard, Sophie Matheron, Sophie Grabar, et al.
AIDS (London, England)|July 19, 2016
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in FranceLaure-Amélie de Monteynard, Sophie Matheron, Jacques Gilquin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2015
High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH StudyLionel Piroth, Hubert Paniez, Anne Marie Taburet, et al.
International Journal of Pharmaceutics|October 9, 2019
Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal modelIria Seoane-Viaño, Noemí Gómez-Lado, Héctor Lázare-Iglesias, et al.
AIDS (London, England)|February 10, 2018
Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timingPierre Gantner, Cindy Barnig, Marialuisa Partisani, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 14, 2026
Systematic Three-Site vs. Classical Single-Site Screening for C. trachomatis and N. gonorrhoeae Infections in Non-Sex Worker Women: The Multicentric SIST'RS StudyThierry Prazuck, Gwenael L E Moal, Axel Ursenbach, et al.
Medicine|October 15, 2016
First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral loadIsabelle Poizot-Martin, Clotilde Allavena, Cyrille Delpierre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2019
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY TrialLaurent Hocqueloux, François Raffi, Thierry Prazuck, et al.
International Journal of Pharmaceutics|October 8, 2022
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat modelXurxo García-Otero, Cristina Mondelo-García, Enrique Bandín-Vilar, et al.
Plos One|March 4, 2015
Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in FranceLaure-Amélie de Monteynard, Rosemary Dray-Spira, Pierre de Truchis, et al.
Plos One|November 1, 2018
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in FranceLaure-Amélie de Monteynard, Sophie Matheron, Sophie Grabar, et al.
AIDS (London, England)|July 19, 2016
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in FranceLaure-Amélie de Monteynard, Sophie Matheron, Jacques Gilquin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2015
High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH StudyLionel Piroth, Hubert Paniez, Anne Marie Taburet, et al.
International Journal of Pharmaceutics|October 9, 2019
Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal modelIria Seoane-Viaño, Noemí Gómez-Lado, Héctor Lázare-Iglesias, et al.
AIDS (London, England)|February 10, 2018
Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timingPierre Gantner, Cindy Barnig, Marialuisa Partisani, et al.
Pageof 11